Suppr超能文献

相似文献

1
Immunology and Immunotherapy of Head and Neck Cancer.
J Clin Oncol. 2015 Oct 10;33(29):3293-304. doi: 10.1200/JCO.2015.61.1509. Epub 2015 Sep 8.
2
Immunotherapy for Head and Neck Cancer.
Hematol Oncol Clin North Am. 2019 Apr;33(2):301-321. doi: 10.1016/j.hoc.2018.12.006.
3
Immunotherapy for Head and Neck Cancer.
Oral Maxillofac Surg Clin North Am. 2019 Feb;31(1):85-100. doi: 10.1016/j.coms.2018.09.002.
4
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma.
Int J Oral Sci. 2021 Aug 2;13(1):24. doi: 10.1038/s41368-021-00131-7.
5
The promise of immunotherapy in head and neck squamous cell carcinoma.
Ann Oncol. 2016 Sep;27(9):1675-85. doi: 10.1093/annonc/mdw226. Epub 2016 Jul 5.
7
Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.
Cancer Treat Rev. 2018 Apr;65:78-86. doi: 10.1016/j.ctrv.2018.03.003. Epub 2018 Mar 20.
8
Biology and immunology of cancer stem(-like) cells in head and neck cancer.
Crit Rev Oncol Hematol. 2015 Sep;95(3):337-45. doi: 10.1016/j.critrevonc.2015.03.009. Epub 2015 Apr 9.
9
Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.
Oncologist. 2017 Jun;22(6):680-693. doi: 10.1634/theoncologist.2016-0318. Epub 2017 May 15.
10
Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects.
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338221150559. doi: 10.1177/15330338221150559.

引用本文的文献

6
Innovative organ-on-a-chip platforms for exploring tumorigenesis and therapy in head and neck cancer.
J Transl Med. 2025 Jul 16;23(1):798. doi: 10.1186/s12967-025-06824-5.
9
Generating tumor-specific T cells based on a head and neck cancer organoid for adoptive cell therapy.
Front Immunol. 2025 Jun 12;16:1573965. doi: 10.3389/fimmu.2025.1573965. eCollection 2025.

本文引用的文献

2
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Nature. 2015 Jan 29;517(7536):576-82. doi: 10.1038/nature14129.
3
PD-1/SHP-2 inhibits Tc1/Th1 phenotypic responses and the activation of T cells in the tumor microenvironment.
Cancer Res. 2015 Feb 1;75(3):508-518. doi: 10.1158/0008-5472.CAN-14-1215. Epub 2014 Dec 5.
4
Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion.
J Immunol. 2014 Aug 15;193(4):1525-30. doi: 10.4049/jimmunol.1400557.
5
The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck.
Oral Oncol. 2014 Jul;50(7):627-32. doi: 10.1016/j.oraloncology.2014.04.003. Epub 2014 May 10.
6
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.
Emerg Infect Dis. 2014 May;20(5):822-8. doi: 10.3201/eid2005.131311.
7
Phase I dendritic cell p53 peptide vaccine for head and neck cancer.
Clin Cancer Res. 2014 May 1;20(9):2433-44. doi: 10.1158/1078-0432.CCR-13-2617. Epub 2014 Feb 28.
8
The immune response in HPV oropharyngeal cancer.
Oncoimmunology. 2014 Jan 1;3(1):e27254. doi: 10.4161/onci.27254.
9
New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.
Curr Opin Immunol. 2014 Apr;27:16-25. doi: 10.1016/j.coi.2014.01.004. Epub 2014 Feb 14.
10
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation.
PLoS One. 2014 Jan 27;9(1):e86551. doi: 10.1371/journal.pone.0086551. eCollection 2014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验